Edelmann establishes Edelmann Leaflet Solutions

Published: 10-Oct-2011
Packaging Finance

New firm is a merger of two of its operations in Germany

The Edelmann Group, a German folding cartons and leaflet specialist, is bundling its activities in the leaflets business into a new company called Edelmann Leaflet Solutions.

The newly founded company will merge two of the Group’s operations in Germany – Lindauer Druckerei Eschbaumer in Lindau and Wepack in Leverkusen.

The Heidenheim-based Edelmann Group extended its leaflets business in June by installing up-to-date folding machines in its facilities and with an overall annual capacity of 1.5 billion units, it is now one Germany’s largest leaflet manufacturers.

The firm says establishing Edelmann Leaflet Solutions will allow orders to be managed outside the individual facilities in Lindau and Leverkusen. This means that capacities can be increased at short notice and the duration of projects shortened while increasing flexibility.

In total Edelmann operates 12 sites serving the healthcare and beauty sectors: in Germany (Carl Edelmann, Artur Theis, Braun Pharmadruck, Lindauer Druckerei Eschbaumer, Wesche and Wepack), France (Edelmann France), Poland (Edelmann Poland), Hungary (Zalai Nyomda), Mexico (Edelmann Mexico) and China (Edelmann Beijing) and employs around 1,500 people.

In 2010, the Group generated revenue of €188m. Worldwide it produced 4.2 billion items of folding cartons and leaflets.

See more

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Read more
Novel solution developed by Schreiner MediPharm and Edelmann

Trending Articles

  1. Smarter weighing for high-dynamic systems New PW22i IO-Link single-point load cell provides precision, speed and intelligence - embedded at sensor level
  2. Romaco Holding GmbH Romaco is a leading international supplier of machinery and integrated system solutions for the development, production and packaging of pharmaceuticals, nutraceuticals, food, cosmetic and chemical products. All from a single source.
  3. Awen Oncology secures seven-figure funding to advance rare bone cancer therapeutic programme The cancer therapeutics company has secured seven-figure funding led by biotech investor Dr Urs Spitz to progress its lead programme targeting a rare form of bone cancer with potential broader oncology applications towards clinical development
  4. NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace harder-to-recycle packaging formats and reduce waste in pharmaceutical manufacturing
  5. Gerresheimer and Milliken partner to advance performance and protection with LeneX UltraGuard technology Up to 40% moisture barrier improvement in HDPE packaging. Enhanced performance, protection, and processing efficiency for demanding pharmaceutical applications

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Novel solution developed by Schreiner MediPharm and Edelmann
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Packaging firms develop smarter options

While serialisation is top of most agendas, the development of Cloud-based services and smart phone solutions also offer new marketing opportunities. Susan Birks reports
Packaging

Edelmann wins Pharmapack Award for vial packaging

Third award won by folding carton concept
Packaging

Edelmann leads development of standard for tamper-evident closures

European working group will publish initial draft this year
Packaging

Edelmann increases label production capacity

Invests in folding machines at three plants
Finance

Sun Pharma to acquire Organon in $11.75bn deal, expanding global manufacturing and biosimilars reach

The firm will acquire Organon in an all-cash $11.75bn transaction, creating a larger global pharma group with expanded manufacturing capacity, stronger women's health operations and a top-10 biosimilars position
Finance

UK biotech venture capital rises 17% in Q1 2026 as deal activity surges 67% year-on-year, BIA figures show

Total UK biotech equity financing reached £552m in the first quarter of 2026, driven by a 17% quarterly rise in venture capital investment, according to BioIndustry Association data, though public markets remain dormant with no IPOs recorded since 2022
Subscribe now